Suhexiang Pill for Acute Ischemic Stroke: A Registry Study
ConditionIschemic Stroke
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDongzhimen Hospital, Beijing
About this trial
The primary purpose of this study is to investigate the effectiveness and safety of the Suhexiang Pill for patients with acute ischemic stroke in real-world settings.
Eligibility criteria
Qualifiers
Acute ischemic stroke within 7 days of symptom onset.
Age ≥ 18
Patient who has received Suhexiang Pill treatment
Patient or legally authorized representative has signed informed consent.
Disqualifiers
Be allergic to Suhexiang Pill
Known to be pregnant or breastfeeding.
With conditions that render outcomes or follow-up unlikely to be assessed.
Trial design
Treatments tested in this trial
- Suhexiang Pill
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov